Search Results

You are looking at 1 - 10 of 190 items for :

  • "Differentiated thyroid cancer" x
Clear All
Free access

Patrick W. Owens, Terri P. McVeigh, Eoin J. Fahey, Marcia Bell, Denis S. Quill, Michael J. Kerin, and Aoife J. Lowery

radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 2011; 75: 112–119. 15 Nixon IJ, Ganly I, Patel SG, Palmer FL

Free access

Mathieu Spaas, Brigitte Decallonne, Annouschka Laenen, Jaak Billen, and Sandra Nuyts

Introduction The vast majority (> 90%) of thyroid carcinomas are differentiated thyroid cancer (DTC), which includes papillary (PTC) and follicular cancer (FTC), characterized by an indolent course and low mortality [ 1 ]. Primary management

Free access

Aamna Hassan, Saima Riaz, Humayun Bashir, M. Khalid Nawaz, and Raza Hussain

Introduction Differentiated thyroid cancer (DTC) is typically indolent if treated early and appropriately. A small subset of more aggressive disease progresses to radioiodine resistance. Based on the American Thyroid Association (ATA) risk of

Free access

Guo-Qiang Zhang, Chen-Tian Shen, Hong-Jun Song, Zhong-Ling Qiu, and Quan-Yong Luo

and the rapid advances in diagnostic radiology tools [ 2 ]. Thyroid cancer is characterized by different clinicopathological properties, and differentiated thyroid cancer (DTC) accounts for more than 90% of thyroid cancer cases [ 3 ]. Although patients

Free access

Fabián Pitoia, Fernando Jerkovich, Anabella Smulever, Gabriela Brenta, Fernanda Bueno, and Graciela Cross

Introduction Various staging systems have historically been used to assess the risk of mortality in patients with differentiated thyroid cancer (DTC) [ 1 , 2 , 3 , 4 , 5 ]. All of them are strongly dependent on patient age since age at

Free access

Cláudia C.D. Nakabashi, Teresa S. Kasamatsu, Felipe Crispim, Claudia A. Yamazaki, Cléber P. Camacho, Danielle M. Andreoni, Rosalia P. Padovani, Elza S. Ikejiri, Maria C.O.M. Mamone, Flávia C. Aldighieri, Jairo Wagner, Jairo T. Hidal, José G.H. Vieira, Rosa P.M. Biscolla, and Rui M.B. Maciel

M, Sherman SI, Steward D, Tuttle RM: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1-48. 10.1089/thy.2009.0110 19860577 6 Tuttle RM: Risk

Free access

Juan J. Lence-Anta, Constance Xhaard, Rosa M. Ortiz, Haoiinda Kassim, Celia M. Pereda, Silvia Turcios, Milagros Velasco, Mae Chappe, Idalmis Infante, Marlene Bustillo, Anabel García, Enora Clero, Stephane Maillard, Sirced Salazar, Regla Rodriguez, and Florent de Vathaire

French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 2010;20:1285-1293. 10.1089/thy.2009.0456 20932181 11 Peterson E, De P, Nuttall R: BMI, diet and female reproductive factors as

Free access

Nicholas S. Andresen, John M. Buatti, Hamed H. Tewfik, Nitin A. Pagedar, Carryn M. Anderson, and John M. Watkins

Introduction Thyroid cancer is the most frequently occurring endocrine cancer, with an increasing incidence noted in the US over the past 15 years [ 1 ]. Papillary and follicular histologic subtypes, known as “differentiated thyroid cancers

Free access

Germán A. Jimenez Londoño, Ana Maria Garcia Vicente, Julia Sastre Marcos, Francisco Jose Pena Pardo, Mariano Amo-Salas, Manuel Moreno Caballero, Maria Prado Talavera Rubio , Beatriz Gonzalez Garcia, Niletys Dafne Disotuar Ruiz, and Angel Maria Soriano Castrejón

low-risk differentiated thyroid cancer (LRDTC) and second, to assess the influence of clinical factors in the therapeutic response. Methods A longitudinal and multicentre study, including 5 hospitals, was performed in accordance with the

Free access

Constance Xhaard, Juan J. Lence-Anta, Yan Ren, Françoise Borson-Chazot, Geneviève Sassolas, Claire Schvartz, Marc Colonna, Brigitte Lacour, Arlette Danzon, Michel Velten, Enora Clero, Stéphane Maillard, Emilie Marrer, Laurent Bailly, Eugènia Mariné Barjoan, Martin Schlumberger, Jacques Orgiazzi, Elisabeth Adjadj, Celia M. Pereda, Silvia Turcios, Milagros Velasco, Mae Chappe, Idalmis Infante, Marlene Bustillo, Anabel García, Sirced Salazar, Regla Rodriguez, Mohamed Amine Benadjaoud, Rosa M. Ortiz, Carole Rubino, and Florent de Vathaire

Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in